As a leading biotechnology company, BOC Sciences provides bridging nucleic acid (BNA) oligonucleotide synthesis services to customers worldwide with its proprietary nucleic acid technology. The third-generation nucleic acid analog, BNA, has better affinity and stability, and can better meet the specific needs of customers.
Service | Custom BNA Oligonucleotide Synthesis | |
Scales |
| |
Modification |
| |
Purification | Desalted, deprotected, PAGE, HPLC, and/or MS | |
Quality Control | All custom BNA are manufactured under strict SOP quality control processes and checked for their quality | |
Price | Inquiry |
Bridging nucleic acid (BNA) is a novel nucleic acid analogue. The first generation BNA, LNA, is a bicyclic nucleotide analogue. LNA has good RNA-specific binding affinity. The second generation BNA, BNANC (2'-O,4'-amino ethylene bridging nucleic acid) is a six-membered bridging oligonucleotide. Oligonucleotides containing BNANC are more thermostable and water-soluble and lead to RNase H degradation of the target RNA. The new generation of BNA contains a five-membered or six-membered bridged structure with a fixed" C3'-endo sugar puckering. This bridge binds to the 2', 4' position of the ribose to obtain a 2', 4'-BNA monomer. The potential of the new generation BNA is the iteration of various BNAs. Such as, the recent synthesis of (S)-cEt-BNA, amino-BNA (AmNA), sulphonamide-BNA, guanidino-BNA and benzylidene acetal-type BNA. Compared with the previous generations of restricted nucleic acids (LNA or BNANC), the new generation of BNA exhibits a remarkably high affinity for its complementary strand. Their extraordinary levels of sensitivity and specificity for nucleic acid resistance make BNAs an excellent tool for the development of high-value detection systems and therapeutic products.
Fig. 1 The structure of BNAcoc and other 2', 4' BNANC nucleic acids. (Kim S, 2015)
Incorporation of BNA into oligonucleotides allows the production of modified synthetic oligonucleotides with the following characteristics:
References
GMP Oligonucleotide Manufacturing Service
For more than 15 years, BOC Sciences has been manufacturing oligonucleotides for pre-clinical, pharmaceutical, food safety, and animal health industries. We provide customized and flexible oligonucleotide GMP or non-GMP production services to meet different production needs.
Lipid Nanoparticle(LNP) for RNA Delivery
BOC Sciences offers comprehensive LNP- mRNA delivery services tailored to meet the specific needs of mRNA vaccine development. Our expertise in nanoparticle formulation and mRNA chemistry enables us to design custom LNP formulations optimized for stability, efficacy, and safety.
BOC Sciences promises to offer you with GalNAc-siRNA conjugation services to help you conduct further research on GalNAc-siRNA conjugates and explore their mores omnics capabilities, the working mechanism as well as their potential therapeutic profiles.
BOC Sciences offers aptamer customization services to generate high-quality aptamers tailored to your goals, delivering excellent results even for the most difficult target molecules.
Peptide-Oligonucleotide Conjugation
BOC Sciences is committed to providing our customers with comprehensive modification and labeling, offering affordable custom oligonucleotides or peptide-oligonucleotide conjugates.